The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow IPOs

By The Online Investor Staff, updated Thu., Oct. 27, 12:51 AM

Slide #1. Ra Pharmaceuticals, Inc. Initial Public Offering

Company: Ra Pharmaceuticals, Inc.
Proposed Symbol: RARX
Shares Offered: 7,049,230
Price Per Share: $13.00
Over-Allotment: 1,057,385
Description: Ra Pharmaceuticals, Inc. ("Ra Pharmaceuticals" or "Ra"), a clinical stage biopharmaceutical company focusing on using its proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system, today announced the pricing of its initial public offering of 7,049,230 shares of common stock at a public offering price of $13.00 per share. In addition, Ra has granted the underwriters a 30-day option to purchase up to 1,057,385 additional shares of common stock at the initial public offering price, less the underwriting discount. Ra's common stock is expected to begin trading on the NASDAQ Global Market under the ticker symbol "RARX" on October 26, 2016.

IPOs: Ra Pharmaceuticals, Inc.

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Fulgent Genetics                        FLGT      
Nutanix                                 NTNX      
Obalon Therapeutics, Inc.               OBLN      
Advanced Disposal Services, Inc.        ADSW      
Coupa Software Incorporated             COUP      
AquaVenture Holdings Limited            WAAS      
Everspin Technologies, Inc.             MRAM      
Avista Healthcare Public Acquisition Corp.AHPAU     
Extraction Oil & Gas, Inc.              XOG       
AzurRx BioPharma Inc.                   AZRX      
Mammoth Energy Services, Inc.           TUSK      
CRISPR Therapeutics AG                  CRSP      
Forterra, Inc.                          FRTA      
iRhythm Technologies, Inc.              IRTC      
Ra Pharmaceuticals, Inc.                RARX      

October 27, 2016    12:51 AM Eastern

IPOs | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.